Association between lower plasma adiponectin levels and higher plasma thrombin generation parameters in men with type 2 diabetes: role of plasma triglycerides
Objective Previous studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in patients with and without type 2 diabetes mellitus (T2DM). Presently, it is uncertain whether lower plasma adiponectin levels are associated with...
Saved in:
Published in: | Journal of endocrinological investigation Vol. 44; no. 3; pp. 547 - 555 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Cham
Springer International Publishing
01-03-2021
Springer Nature B.V |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Objective
Previous studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in patients with and without type 2 diabetes mellitus (T2DM). Presently, it is uncertain whether lower plasma adiponectin levels are associated with greater plasma thrombin generation in patients with T2DM.
Patients and methods
We studied 82 middle-aged men with non-insulin-treated T2DM [mean age ± SD: 64.1 ± 8 years; median duration of diabetes: 12.5 (inter-quartile range 6–19) years; mean hemoglobin A1c 7.0 ± 0.7%], consecutively attending our diabetes outpatient service over a 6-month period. Using the newly developed fully automated thrombin generation analyzer ST Genesia®, we measured the plasma parameters lag time (LT), time to peak (TP), peak height (PH) and endogenous thrombin potential (ETP) in all participants.
Results
In univariable linear regression analyses, lower plasma adiponectin levels were significantly associated with higher plasma thrombin generation parameters, as reflected by higher values of PH (Pearson’s
r
coefficient = − 0.228,
p
= 0.039) and EPT (
r
= − 0.293,
p
= 0.007). Plasma adiponectin levels were not significantly associated with other thrombin generation parameters (LT and TP). Notably, the significant associations of plasma adiponectin levels with thrombin PH and EPT values persisted after adjustment for age and adiposity measures, but they were lost after additional adjustment for plasma triglycerides.
Conclusion
Our findings show for the first time the existence of a significant association between lower levels of plasma adiponectin and greater plasma thrombin generation (as assessed by the ST Genesia® analyzer) in men with non-insulin-treated T2DM, which appears to be largely mediated by plasma triglycerides. |
---|---|
AbstractList | OBJECTIVEPrevious studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in patients with and without type 2 diabetes mellitus (T2DM). Presently, it is uncertain whether lower plasma adiponectin levels are associated with greater plasma thrombin generation in patients with T2DM. PATIENTS AND METHODSWe studied 82 middle-aged men with non-insulin-treated T2DM [mean age ± SD: 64.1 ± 8 years; median duration of diabetes: 12.5 (inter-quartile range 6-19) years; mean hemoglobin A1c 7.0 ± 0.7%], consecutively attending our diabetes outpatient service over a 6-month period. Using the newly developed fully automated thrombin generation analyzer ST Genesia®, we measured the plasma parameters lag time (LT), time to peak (TP), peak height (PH) and endogenous thrombin potential (ETP) in all participants. RESULTSIn univariable linear regression analyses, lower plasma adiponectin levels were significantly associated with higher plasma thrombin generation parameters, as reflected by higher values of PH (Pearson's r coefficient = - 0.228, p = 0.039) and EPT (r = - 0.293, p = 0.007). Plasma adiponectin levels were not significantly associated with other thrombin generation parameters (LT and TP). Notably, the significant associations of plasma adiponectin levels with thrombin PH and EPT values persisted after adjustment for age and adiposity measures, but they were lost after additional adjustment for plasma triglycerides. CONCLUSIONOur findings show for the first time the existence of a significant association between lower levels of plasma adiponectin and greater plasma thrombin generation (as assessed by the ST Genesia® analyzer) in men with non-insulin-treated T2DM, which appears to be largely mediated by plasma triglycerides. Previous studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in patients with and without type 2 diabetes mellitus (T2DM). Presently, it is uncertain whether lower plasma adiponectin levels are associated with greater plasma thrombin generation in patients with T2DM. We studied 82 middle-aged men with non-insulin-treated T2DM [mean age ± SD: 64.1 ± 8 years; median duration of diabetes: 12.5 (inter-quartile range 6-19) years; mean hemoglobin A1c 7.0 ± 0.7%], consecutively attending our diabetes outpatient service over a 6-month period. Using the newly developed fully automated thrombin generation analyzer ST Genesia®, we measured the plasma parameters lag time (LT), time to peak (TP), peak height (PH) and endogenous thrombin potential (ETP) in all participants. In univariable linear regression analyses, lower plasma adiponectin levels were significantly associated with higher plasma thrombin generation parameters, as reflected by higher values of PH (Pearson's r coefficient = - 0.228, p = 0.039) and EPT (r = - 0.293, p = 0.007). Plasma adiponectin levels were not significantly associated with other thrombin generation parameters (LT and TP). Notably, the significant associations of plasma adiponectin levels with thrombin PH and EPT values persisted after adjustment for age and adiposity measures, but they were lost after additional adjustment for plasma triglycerides. Our findings show for the first time the existence of a significant association between lower levels of plasma adiponectin and greater plasma thrombin generation (as assessed by the ST Genesia® analyzer) in men with non-insulin-treated T2DM, which appears to be largely mediated by plasma triglycerides. Objective Previous studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in patients with and without type 2 diabetes mellitus (T2DM). Presently, it is uncertain whether lower plasma adiponectin levels are associated with greater plasma thrombin generation in patients with T2DM. Patients and methods We studied 82 middle-aged men with non-insulin-treated T2DM [mean age ± SD: 64.1 ± 8 years; median duration of diabetes: 12.5 (inter-quartile range 6–19) years; mean hemoglobin A1c 7.0 ± 0.7%], consecutively attending our diabetes outpatient service over a 6-month period. Using the newly developed fully automated thrombin generation analyzer ST Genesia®, we measured the plasma parameters lag time (LT), time to peak (TP), peak height (PH) and endogenous thrombin potential (ETP) in all participants. Results In univariable linear regression analyses, lower plasma adiponectin levels were significantly associated with higher plasma thrombin generation parameters, as reflected by higher values of PH (Pearson’s r coefficient = − 0.228, p = 0.039) and EPT ( r = − 0.293, p = 0.007). Plasma adiponectin levels were not significantly associated with other thrombin generation parameters (LT and TP). Notably, the significant associations of plasma adiponectin levels with thrombin PH and EPT values persisted after adjustment for age and adiposity measures, but they were lost after additional adjustment for plasma triglycerides. Conclusion Our findings show for the first time the existence of a significant association between lower levels of plasma adiponectin and greater plasma thrombin generation (as assessed by the ST Genesia® analyzer) in men with non-insulin-treated T2DM, which appears to be largely mediated by plasma triglycerides. ObjectivePrevious studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in patients with and without type 2 diabetes mellitus (T2DM). Presently, it is uncertain whether lower plasma adiponectin levels are associated with greater plasma thrombin generation in patients with T2DM. Patients and methodsWe studied 82 middle-aged men with non-insulin-treated T2DM [mean age ± SD: 64.1 ± 8 years; median duration of diabetes: 12.5 (inter-quartile range 6–19) years; mean hemoglobin A1c 7.0 ± 0.7%], consecutively attending our diabetes outpatient service over a 6-month period. Using the newly developed fully automated thrombin generation analyzer ST Genesia®, we measured the plasma parameters lag time (LT), time to peak (TP), peak height (PH) and endogenous thrombin potential (ETP) in all participants. ResultsIn univariable linear regression analyses, lower plasma adiponectin levels were significantly associated with higher plasma thrombin generation parameters, as reflected by higher values of PH (Pearson’s r coefficient = − 0.228, p = 0.039) and EPT (r = − 0.293, p = 0.007). Plasma adiponectin levels were not significantly associated with other thrombin generation parameters (LT and TP). Notably, the significant associations of plasma adiponectin levels with thrombin PH and EPT values persisted after adjustment for age and adiposity measures, but they were lost after additional adjustment for plasma triglycerides.ConclusionOur findings show for the first time the existence of a significant association between lower levels of plasma adiponectin and greater plasma thrombin generation (as assessed by the ST Genesia® analyzer) in men with non-insulin-treated T2DM, which appears to be largely mediated by plasma triglycerides. |
Author | Targher, G. Danese, E. Mantovani, A. Lippi, G. Salvagno, G. L. Bovo, C. Gelati, M. Turino, T. |
Author_xml | – sequence: 1 givenname: A. surname: Mantovani fullname: Mantovani, A. email: alessandro.mantovani@univr.it organization: Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona – sequence: 2 givenname: E. surname: Danese fullname: Danese, E. organization: Section of Clinical Biochemistry, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona – sequence: 3 givenname: G. L. surname: Salvagno fullname: Salvagno, G. L. organization: Section of Clinical Biochemistry, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona – sequence: 4 givenname: M. surname: Gelati fullname: Gelati, M. organization: Section of Clinical Biochemistry, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona – sequence: 5 givenname: T. surname: Turino fullname: Turino, T. organization: Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona – sequence: 6 givenname: C. surname: Bovo fullname: Bovo, C. organization: Medical Direction, University and Azienda Ospedaliera Universitaria Integrata of Verona – sequence: 7 givenname: G. surname: Lippi fullname: Lippi, G. organization: Section of Clinical Biochemistry, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona – sequence: 8 givenname: G. surname: Targher fullname: Targher, G. organization: Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32588382$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtv3CAUhVGVKu8_0EWE1E03bnnYBrKLojatFKmbZI0wvp4hssEBpqP5M_2tJXFeyqIr4J7vnoN0jtCeDx4Q-kTJV0qI-JZq0lJZEUYqQnlNKv4BHVJRnpLLdu_N_QAdpXRHCBdcin10wFkjy5wdor8XKQXrTHbB4w7yFsDjMWwh4nk0aTLY9G4uuTa7IsAfGBM2vsdrt1q_Qnkdw9QVYgUe4uI2m2gmyBATLsJUfLcur3HezYAZ7p0pcZDOcQwj4DC8WEW3GncWoushnaCPgxkTnD6dx-j2x_eby5_V9e-rX5cX15XlosmVbQyrhRqolYoB7TtpDAgBA-951xlKhZJqAMVrYA0bGkWJ6hquoDdWQVvzY_Rl8Z1juN9AynpyycI4Gg9hkzSrqaRMtEQW9PM79C5soi-_K5SUrWJMNoViC2VjSCnCoOfoJhN3mhL90J5e2tOlPf3YnuZl6ezJetNN0L-sPNdVAL4AqUh-BfE1-z-2_wCCJaop |
CitedBy_id | crossref_primary_10_1111_jth_15657 crossref_primary_10_1007_s42000_022_00387_6 crossref_primary_10_3390_nu13061774 |
Cites_doi | 10.1007/s11239-013-1026-5 10.1530/EJE-09-0958 10.1055/s-0030-1248723 10.1055/s-0037-1608942 10.1161/01.ATV.0000048856.22331.50 10.1016/S0140-6736(14)61177-6 10.1210/jc.2006-1067 10.1111/obr.12064 10.7326/0003-4819-150-9-200905050-00006 10.1111/j.1463-1326.2005.00510.x 10.1001/jama.291.14.1730 10.1515/cclm-2019-0135 10.1159/000071636 10.3390/ijms20051190 10.1093/eurheartj/ehz455 10.1159/000480006 10.1038/nrcardio.2017.31 10.1016/j.atherosclerosis.2011.07.011 10.1016/j.metabol.2006.08.005 10.1097/MD.0000000000004495 10.1074/jbc.270.45.26746 10.1111/j.1365-2265.2006.02527.x 10.1152/ajpendo.00728.2009 10.1111/j.1538-7836.2012.04782.x 10.1373/clinchem.2015.248625 10.1186/s12944-019-1168-3 10.2337/dc19-S011 10.1016/j.diabet.2019.11.004 10.3390/ijms18061321 |
ContentType | Journal Article |
Copyright | Italian Society of Endocrinology (SIE) 2020 Italian Society of Endocrinology (SIE) 2020. |
Copyright_xml | – notice: Italian Society of Endocrinology (SIE) 2020 – notice: Italian Society of Endocrinology (SIE) 2020. |
DBID | NPM AAYXX CITATION 7X8 |
DOI | 10.1007/s40618-020-01340-3 |
DatabaseName | PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1720-8386 |
EndPage | 555 |
ExternalDocumentID | 10_1007_s40618_020_01340_3 32588382 |
Genre | Journal Article |
GroupedDBID | --- -EM .GJ 203 4.4 406 53G 5GY 5RE 8RF 8YF 96X AABYN AAFGU AAHNG AAIAL AAJKR AAKSU AANXM AANZL AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO AAZMS ABDZT ABECU ABFGW ABFTV ABHLI ABIPD ABJNI ABJOX ABKAS ABKCH ABMQK ABPLI ABQBU ABTEG ABTKH ABTMW ABXPI ACBMV ACBRV ACBYP ACGFS ACHSB ACIGE ACIPQ ACKNC ACMLO ACOKC ACPRK ACTTH ACUDM ACVWB ACWMK ADHHG ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADURQ ADYFF ADZKW AEBTG AEEQQ AEFTE AEGNC AEJHL AEJRE AEKMD AENEX AEODN AEOHA AEPYU AESKC AESTI AETCA AEVLU AEVTX AEXYK AFAFS AFNRJ AFQWF AFZKB AGAYW AGDGC AGGBP AGJBK AGKHE AGMZJ AGQMX AGWZB AGYKE AHAVH AHBYD AHIZS AHSBF AI. AIAKS AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKLTO AKMHD AKQUC ALFXC ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AMYQR ANMIH ASPBG AUKKA AVWKF AXYYD AZFZN BGNMA CSCUP DNIVK DPUIP EBLON EBS EIOEI EJD ESBYG F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FYJPI GGCAI GGRSB GJIRD GQ6 GQ7 GRRUI HG6 HRMNR I0C IKXTQ IMOTQ ITM IWAJR J-C JBSCW JZLTJ KOV LLZTM M4Y NPVJJ NQJWS NU0 O93 O9G O9J P2P PT4 RHV RLLFE RSV SCLPG SDE SHX SISQX SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE TSG U9L UG4 UOJIU UTJUX UZXMN VFIZW VH1 W48 Z7U Z7W Z82 Z83 Z87 ZA5 ZGI ZMTXR ZOVNA ZXP 0R~ AACDK AAEOY AAEWM AAJBT AASML ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU AJOOF NPM ROL SJYHP AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c375t-c5a2479f1c892e1db8aae77ef3d3bba117989fe934e252f59109b539edac9e643 |
IEDL.DBID | AEJHL |
ISSN | 1720-8386 0391-4097 |
IngestDate | Fri Oct 25 02:42:10 EDT 2024 Thu Nov 21 04:11:09 EST 2024 Thu Nov 21 21:27:15 EST 2024 Sat Sep 28 08:29:31 EDT 2024 Sat Dec 16 12:10:05 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Type 2 diabetes Triglycerides Plasma thrombin generation Adiponectin |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c375t-c5a2479f1c892e1db8aae77ef3d3bba117989fe934e252f59109b539edac9e643 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 32588382 |
PQID | 2488692285 |
PQPubID | 2043718 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2418127608 proquest_journals_2488692285 crossref_primary_10_1007_s40618_020_01340_3 pubmed_primary_32588382 springer_journals_10_1007_s40618_020_01340_3 |
PublicationCentury | 2000 |
PublicationDate | 2021-03-01 |
PublicationDateYYYYMMDD | 2021-03-01 |
PublicationDate_xml | – month: 03 year: 2021 text: 2021-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: Italy – name: Heidelberg |
PublicationSubtitle | Official Journal of Italian Society of Endocrinology (SIE) |
PublicationTitle | Journal of endocrinological investigation |
PublicationTitleAbbrev | J Endocrinol Invest |
PublicationTitleAlternate | J Endocrinol Invest |
PublicationYear | 2021 |
Publisher | Springer International Publishing Springer Nature B.V |
Publisher_xml | – name: Springer International Publishing – name: Springer Nature B.V |
References | Reiner (CR25) 2017; 14 Ebrahimi-Mamaeghani, Mohammadi, Arefhosseini, Fallah, Bazi (CR5) 2015; 11 Scherer, Williams, Fogliano, Baldini, Lodish (CR1) 1995; 270 CR16 Hemker, Giesen, Al Dieri, Regnault, de Smedt, Wagenvoord, Lecompte, Béguin (CR15) 2003; 33 Mach, Baigent, Catapano, Koskinas, Casula, Badimon, Chapman, De Backer, Delgado, Ference, Graham, Halliday, Landmesser, Mihaylova, Pedersen, Riccardi, Richter, Sabatine, Taskinen, Tokgozoglu, Wiklund (CR27) 2020; 41 Yang, Li, Zhao, Zhang (CR10) 2019; 18 Chitongo, Roberts, Yang, Patel, Lyall, Luxton, Aylwin, Arya (CR19) 2017; 1 Targher, Zoppini, Moghetti, Day (CR28) 2010; 36 Levey, Stevens, Schmid, Zhang, Castro, Feldman, Kusek, Eggers, Van Lente, Greene, Coresh (CR17) 2009; 150 Pischon, Girman, Hotamisligil, Rifai, Hu, Rimm (CR9) 2004; 291 Christou, Kiortsis (CR22) 2013; 14 (CR18) 2019; 42 Chen, Zheng, Liu, Lin, Liao, Xin, Zhong, Cheng, Zhang (CR24) 2017; 42 Franchini, Lippi, Manzato, Vescovi, Targher (CR29) 2010; 162 CR2 Targher, Bertolini, Rodella, Zoppini, Scala, Zenari, Falezza (CR4) 2006; 64 Tripodi (CR14) 2016; 62 Pischon, Hu, Girman, Rifai, Manson, Rexrode, Rimm (CR20) 2011; 219 Kalz, ten Cate, Spronk (CR11) 2014; 37 Salvagno, Favaloro, Demonte, Gelati, Poli, Targher, Lippi (CR13) 2019; 57 Kumada, Kihara, Sumitsuji, Kawamoto, Matsumoto, Ouchi, Arita, Okamoto, Shimomura, Hiraoka, Nakamura, Funahashi, Matsuzawa (CR6) 2003; 23 Frystyk, Berne, Berglund, Jensevik, Flyvbjerg, Zethelius (CR7) 2007; 92 Hashimoto, Kanda, Nakamura, Horie, Kurosawa, Hashimoto, Sato, Kushida, Suzuki, Yano, Iwai, Takahashi, Yoshida (CR8) 2006; 55 Restituto, Colina, Varo, Varo (CR23) 2010; 298 Nordestgaard, Varbo (CR26) 2014; 384 Loeffen, Spronk, ten Cate (CR12) 2012; 10 Yanai, Yoshida (CR21) 2019; 20 Mi, Yan, Lu, Liang, Li (CR30) 2016; 95 Whitehead, Richards, Hickman, Macdonald, Prins (CR3) 2006; 8 PE Scherer (1340_CR1) 1995; 270 HC Hemker (1340_CR15) 2003; 33 AS Levey (1340_CR17) 2009; 150 G Targher (1340_CR28) 2010; 36 1340_CR2 JP Whitehead (1340_CR3) 2006; 8 M Ebrahimi-Mamaeghani (1340_CR5) 2015; 11 G Targher (1340_CR4) 2006; 64 L Yang (1340_CR10) 2019; 18 T Pischon (1340_CR20) 2011; 219 Y Mi (1340_CR30) 2016; 95 H Yanai (1340_CR21) 2019; 20 PB Chitongo (1340_CR19) 2017; 1 P Restituto (1340_CR23) 2010; 298 Y Chen (1340_CR24) 2017; 42 R Loeffen (1340_CR12) 2012; 10 F Mach (1340_CR27) 2020; 41 Ž Reiner (1340_CR25) 2017; 14 BG Nordestgaard (1340_CR26) 2014; 384 American Diabetes Association (1340_CR18) 2019; 42 J Frystyk (1340_CR7) 2007; 92 1340_CR16 M Franchini (1340_CR29) 2010; 162 T Pischon (1340_CR9) 2004; 291 N Hashimoto (1340_CR8) 2006; 55 M Kumada (1340_CR6) 2003; 23 A Tripodi (1340_CR14) 2016; 62 GA Christou (1340_CR22) 2013; 14 GL Salvagno (1340_CR13) 2019; 57 J Kalz (1340_CR11) 2014; 37 |
References_xml | – volume: 37 start-page: 45 year: 2014 end-page: 55 ident: CR11 article-title: Thrombin generation and atherosclerosis publication-title: J Thromb Thrombolysis doi: 10.1007/s11239-013-1026-5 contributor: fullname: Spronk – volume: 162 start-page: 439 year: 2010 end-page: 451 ident: CR29 article-title: Hemostatic abnormalities in endocrine and metabolic disorders publication-title: Eur J Endocrinol doi: 10.1530/EJE-09-0958 contributor: fullname: Targher – volume: 36 start-page: 41 year: 2010 end-page: 48 ident: CR28 article-title: Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver publication-title: Semin Thromb Hemost doi: 10.1055/s-0030-1248723 contributor: fullname: Day – volume: 11 start-page: 55 year: 2015 end-page: 70 ident: CR5 article-title: Adiponectin as a potential biomarker of vascular disease publication-title: Vasc Health Risk Manag contributor: fullname: Bazi – ident: CR2 – ident: CR16 – volume: 1 start-page: e146 year: 2017 end-page: e154 ident: CR19 article-title: Visceral adiposity is an independent determinant of hypercoagulability as measured by thrombin generation in morbid obesity publication-title: TH Open doi: 10.1055/s-0037-1608942 contributor: fullname: Arya – volume: 23 start-page: 85 year: 2003 end-page: 89 ident: CR6 article-title: Association of hypoadiponectinemia with coronary artery disease in men publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000048856.22331.50 contributor: fullname: Matsuzawa – volume: 384 start-page: 626 year: 2014 end-page: 635 ident: CR26 article-title: Triglycerides and cardiovascular disease publication-title: Lancet doi: 10.1016/S0140-6736(14)61177-6 contributor: fullname: Varbo – volume: 92 start-page: 571 year: 2007 end-page: 576 ident: CR7 article-title: Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2006-1067 contributor: fullname: Zethelius – volume: 14 start-page: 939 year: 2013 end-page: 949 ident: CR22 article-title: Adiponectin and lipoprotein metabolism publication-title: Obes Rev doi: 10.1111/obr.12064 contributor: fullname: Kiortsis – volume: 150 start-page: 604 year: 2009 end-page: 612 ident: CR17 article-title: A new equation to estimate glomerular filtration rate publication-title: Ann Intern Med doi: 10.7326/0003-4819-150-9-200905050-00006 contributor: fullname: Coresh – volume: 8 start-page: 264 year: 2006 end-page: 280 ident: CR3 article-title: Adiponectin-a key adipokine in the metabolic syndrome publication-title: Diabetes Obes Metab doi: 10.1111/j.1463-1326.2005.00510.x contributor: fullname: Prins – volume: 291 start-page: 1730 year: 2004 end-page: 1737 ident: CR9 article-title: Plasma adiponectin levels and risk of myocardial infarction in men publication-title: JAMA doi: 10.1001/jama.291.14.1730 contributor: fullname: Rimm – volume: 57 start-page: 1784 year: 2019 end-page: 1789 ident: CR13 article-title: Influence of hypertriglyceridemia, hyperbilirubinemia and hemolysis on thrombin generation in human plasma publication-title: Clin Chem Lab Med doi: 10.1515/cclm-2019-0135 contributor: fullname: Lippi – volume: 33 start-page: 4 year: 2003 end-page: 15 ident: CR15 article-title: Calibrated automated thrombin generation measurement in clotting plasma publication-title: Pathophysiol Haemost Thromb doi: 10.1159/000071636 contributor: fullname: Béguin – volume: 20 start-page: 1190 year: 2019 ident: CR21 article-title: beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives publication-title: Int J Mol Sci doi: 10.3390/ijms20051190 contributor: fullname: Yoshida – volume: 41 start-page: 111 year: 2020 end-page: 188 ident: CR27 article-title: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk publication-title: Eur Heart J doi: 10.1093/eurheartj/ehz455 contributor: fullname: Wiklund – volume: 42 start-page: 2342 year: 2017 end-page: 2352 ident: CR24 article-title: Adiponectin inhibits TNF-α-activated PAI-1 expression via the cAMP-PKA-AMPK-NF-κB axis in human umbilical vein endothelial cells publication-title: Cell Physiol Biochem doi: 10.1159/000480006 contributor: fullname: Zhang – volume: 14 start-page: 401 year: 2017 end-page: 411 ident: CR25 article-title: Hypertriglyceridaemia and risk of coronary artery disease publication-title: Nat Rev Cardiol doi: 10.1038/nrcardio.2017.31 contributor: fullname: Reiner – volume: 219 start-page: 322 year: 2011 end-page: 329 ident: CR20 article-title: Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2011.07.011 contributor: fullname: Rimm – volume: 55 start-page: 1653 year: 2006 end-page: 1657 ident: CR8 article-title: Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses publication-title: Metabolism doi: 10.1016/j.metabol.2006.08.005 contributor: fullname: Yoshida – volume: 95 start-page: e4495 year: 2016 ident: CR30 article-title: Venous thromboembolism has the same risk factors as atherosclerosis: a PRISMA-compliant systemic review and meta-analysis publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000004495 contributor: fullname: Li – volume: 270 start-page: 26746 year: 1995 end-page: 26749 ident: CR1 article-title: A novel serum protein similar to c1q, produced exclusively in adipocytes publication-title: J Biol Chem doi: 10.1074/jbc.270.45.26746 contributor: fullname: Lodish – volume: 64 start-page: 679 year: 2006 end-page: 683 ident: CR4 article-title: Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease publication-title: Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.2006.02527.x contributor: fullname: Falezza – volume: 298 start-page: E1072 year: 2010 end-page: 1077 ident: CR23 article-title: Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00728.2009 contributor: fullname: Varo – volume: 10 start-page: 1207 year: 2012 end-page: 1216 ident: CR12 article-title: The impact of blood coagulability on atherosclerosis and cardiovascular disease publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2012.04782.x contributor: fullname: ten Cate – volume: 62 start-page: 699 year: 2016 end-page: 707 ident: CR14 article-title: Thrombin generation assay and its application in the clinical laboratory publication-title: Clin Chem doi: 10.1373/clinchem.2015.248625 contributor: fullname: Tripodi – volume: 18 start-page: 227 year: 2019 ident: CR10 article-title: Prognostic value of adiponectin level in patients with coronary artery disease: a systematic review and meta-analysis publication-title: Lipids Health Dis doi: 10.1186/s12944-019-1168-3 contributor: fullname: Zhang – volume: 42 start-page: S124 issue: suppl 1 year: 2019 end-page: S138 ident: CR18 article-title: Microvascular complications and foot care: standards of medical care in diabetes-2019 publication-title: Diabetes Care doi: 10.2337/dc19-S011 – volume: 298 start-page: E1072 year: 2010 ident: 1340_CR23 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00728.2009 contributor: fullname: P Restituto – volume: 8 start-page: 264 year: 2006 ident: 1340_CR3 publication-title: Diabetes Obes Metab doi: 10.1111/j.1463-1326.2005.00510.x contributor: fullname: JP Whitehead – volume: 11 start-page: 55 year: 2015 ident: 1340_CR5 publication-title: Vasc Health Risk Manag contributor: fullname: M Ebrahimi-Mamaeghani – volume: 1 start-page: e146 year: 2017 ident: 1340_CR19 publication-title: TH Open doi: 10.1055/s-0037-1608942 contributor: fullname: PB Chitongo – volume: 55 start-page: 1653 year: 2006 ident: 1340_CR8 publication-title: Metabolism doi: 10.1016/j.metabol.2006.08.005 contributor: fullname: N Hashimoto – volume: 291 start-page: 1730 year: 2004 ident: 1340_CR9 publication-title: JAMA doi: 10.1001/jama.291.14.1730 contributor: fullname: T Pischon – volume: 95 start-page: e4495 year: 2016 ident: 1340_CR30 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000004495 contributor: fullname: Y Mi – volume: 10 start-page: 1207 year: 2012 ident: 1340_CR12 publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2012.04782.x contributor: fullname: R Loeffen – volume: 64 start-page: 679 year: 2006 ident: 1340_CR4 publication-title: Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.2006.02527.x contributor: fullname: G Targher – volume: 23 start-page: 85 year: 2003 ident: 1340_CR6 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000048856.22331.50 contributor: fullname: M Kumada – volume: 92 start-page: 571 year: 2007 ident: 1340_CR7 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2006-1067 contributor: fullname: J Frystyk – ident: 1340_CR16 doi: 10.1016/j.diabet.2019.11.004 – volume: 36 start-page: 41 year: 2010 ident: 1340_CR28 publication-title: Semin Thromb Hemost doi: 10.1055/s-0030-1248723 contributor: fullname: G Targher – volume: 57 start-page: 1784 year: 2019 ident: 1340_CR13 publication-title: Clin Chem Lab Med doi: 10.1515/cclm-2019-0135 contributor: fullname: GL Salvagno – volume: 384 start-page: 626 year: 2014 ident: 1340_CR26 publication-title: Lancet doi: 10.1016/S0140-6736(14)61177-6 contributor: fullname: BG Nordestgaard – volume: 162 start-page: 439 year: 2010 ident: 1340_CR29 publication-title: Eur J Endocrinol doi: 10.1530/EJE-09-0958 contributor: fullname: M Franchini – volume: 14 start-page: 401 year: 2017 ident: 1340_CR25 publication-title: Nat Rev Cardiol doi: 10.1038/nrcardio.2017.31 contributor: fullname: Ž Reiner – volume: 150 start-page: 604 year: 2009 ident: 1340_CR17 publication-title: Ann Intern Med doi: 10.7326/0003-4819-150-9-200905050-00006 contributor: fullname: AS Levey – volume: 14 start-page: 939 year: 2013 ident: 1340_CR22 publication-title: Obes Rev doi: 10.1111/obr.12064 contributor: fullname: GA Christou – volume: 42 start-page: S124 issue: suppl 1 year: 2019 ident: 1340_CR18 publication-title: Diabetes Care doi: 10.2337/dc19-S011 contributor: fullname: American Diabetes Association – volume: 41 start-page: 111 year: 2020 ident: 1340_CR27 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehz455 contributor: fullname: F Mach – volume: 42 start-page: 2342 year: 2017 ident: 1340_CR24 publication-title: Cell Physiol Biochem doi: 10.1159/000480006 contributor: fullname: Y Chen – volume: 62 start-page: 699 year: 2016 ident: 1340_CR14 publication-title: Clin Chem doi: 10.1373/clinchem.2015.248625 contributor: fullname: A Tripodi – volume: 33 start-page: 4 year: 2003 ident: 1340_CR15 publication-title: Pathophysiol Haemost Thromb doi: 10.1159/000071636 contributor: fullname: HC Hemker – ident: 1340_CR2 doi: 10.3390/ijms18061321 – volume: 37 start-page: 45 year: 2014 ident: 1340_CR11 publication-title: J Thromb Thrombolysis doi: 10.1007/s11239-013-1026-5 contributor: fullname: J Kalz – volume: 20 start-page: 1190 year: 2019 ident: 1340_CR21 publication-title: Int J Mol Sci doi: 10.3390/ijms20051190 contributor: fullname: H Yanai – volume: 270 start-page: 26746 year: 1995 ident: 1340_CR1 publication-title: J Biol Chem doi: 10.1074/jbc.270.45.26746 contributor: fullname: PE Scherer – volume: 18 start-page: 227 year: 2019 ident: 1340_CR10 publication-title: Lipids Health Dis doi: 10.1186/s12944-019-1168-3 contributor: fullname: L Yang – volume: 219 start-page: 322 year: 2011 ident: 1340_CR20 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2011.07.011 contributor: fullname: T Pischon |
SSID | ssj0037387 |
Score | 2.3515136 |
Snippet | Objective
Previous studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in... Previous studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in patients with... ObjectivePrevious studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in... OBJECTIVEPrevious studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in... |
SourceID | proquest crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 547 |
SubjectTerms | Adiponectin Adipose tissue Cardiovascular diseases Diabetes Diabetes mellitus (non-insulin dependent) Endocrinology Hemoglobin Insulin Internal Medicine Medicine Medicine & Public Health Metabolic Diseases Original Article Plasma Thrombin Triglycerides |
Title | Association between lower plasma adiponectin levels and higher plasma thrombin generation parameters in men with type 2 diabetes: role of plasma triglycerides |
URI | https://link.springer.com/article/10.1007/s40618-020-01340-3 https://www.ncbi.nlm.nih.gov/pubmed/32588382 https://www.proquest.com/docview/2488692285 https://search.proquest.com/docview/2418127608 |
Volume | 44 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwEB4VkCoutKX8BGhlpN5KEGvHa5sbane7RcClVOotcmJ7QbDZFWEPvAzP2hlvkraiPdBTDnYmjmc8M54Zfwb4kIXMHknu0uC5SjNV9FJd8H4aQtDBeCf6EYlp9E1d_NCfBwSTI7rQRXVz2GYko6LuzrqR5dEp7XbQa8lQeSzBCtoeicK9cjI4HZ21CpiwelRzPubvb_5pg544lk-SotHWDF_91yhfw1rjWrKThSy8gRe-WoeX503y_C08_sYK1tRnsVu6JY3N0IeeWGbd9WxakQrEBqomqpmtHLuKtSBtJ7pYYYL7aTaOiNWRGgGIT6iwpmbYMEG6FN9lFN9lnLXx3WNGtYxsGjpSd9fj24cSF4Hz9QZ8Hw4uP43S5nqGtBRK3qeltDxTJvRKbbjvuUJb65XyQThRFJaw5rQJ3ojMc8mDRMfEFFKgANjSePSENmG5wp_aBmYJtKdwATdjPEOjapCu0QX2lR6Np0vgY8uwfLZA4cg7vOU45TlOeR6nPBcJ7LU8zZsVWeccNVXfcK5lAvtdM64lSpDYyk_n1If8HdU_0glsLWSh-5zgUmuheQIHLed_Ef_3WHae130XVjkVzcQitz1Yvr-b-3ewVLv5-0bK6fn18svwJ7t5-wY |
link.rule.ids | 315,782,786,27933,27934,41073,42142,48344,48347,49649,49652,52153 |
linkProvider | Springer Nature |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RVgIuvB-hLRiJG0Tq-hHbvVXQZSvaXrpI3CIntkulbnbVdA_8GX4rM94kFJUe2rOdSeIZz4w9nz8DfJBRuh3FfR4D17nU1Sg3FS_yGKOJNnhRJCamyYk-_mG-7BNNjuzPwiS0e1-STJ56OOxGocfktNzBtEWi91iDDWkLiba8sXcw_TruPTCR9ejugMz_n_w3CF3LLK9VRVOwGT--22c-gUddcsn2VtbwFO6F5hncP-rK58_h9xVlsA6hxc7pnjS2wCx65pjzZ4t5Q04QGwhP1DLXePYzoUH6TnS1wgxX1Ow0cVYnaUQhPiNoTcuwYYZyaYeX0Q4v46zf4d1lhGZk8ziIujg7Pf9V4zTwoX0B38f708-TvLugIa-FVpd5rRyX2sZRbSwPI18Z54LWIQovqsoR25yxMVghA1c8KkxNbKUEmoCrbcBc6CWsN_hTr4E5ou2pfMTlGJcYVi3KtabCvipg-PQZfOw1Vi5WPBzlwLichrzEIS_TkJcig61eqWU3J9uSo68qLOdGZfB-aMbZRCUS14T5kvpQxqOLHZPBq5UxDK8TXBkjDM_gU6_5v8Jv_pY3t-v-Dh5MpkeH5eHB8bdNeMgJQpMgb1uwfnmxDNuw1vrl287k_wDguf1o |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NTtwwEB4VkFAv0AKlobQ1ErcSwdrx2u4NlV1tC0VIFIlb5MQ2RWKzK7J74GX6rJ3xJikV7aHq2ZNJYo_nxzPzGWA_C5k9ktylwXOVZqropbrg_TSEoIPxTvQjEtPoUp1f65MBweR0Xfyx2r1NSS56GgilqZodTl047BrfyAzplEIfdGEy1CRLsJJhJIOSvnI8-DI6a7UxAfeoplnmz0_-bpCeeJlPMqTR8AzX__-TX8Ba43Sy44WUvIRnvtqA1a9NWn0TfjxaJNZUbrE7uj-NTdG7Hltm3e10UpFyxAGqM6qZrRz7HqtEWiK6cmGMkTa7iVjWkRtBi4-p5KZmODBGvnTyy-jkl3HWnvx-ZFTlyCahY3V_e3P3UOL2cL7egqvh4NunUdpc3JCWQslZWkrLM2VCr9SG-54rtLVeKR-EE0VhCYVOm-CNyDyXPEh0WUwhBYqGLY1HH-kVLFf4U6-BWYLzKVzAMI1naG4N8jW6QFrp0ay6BD60q5dPF_gceYfEHKc8xynP45TnIoHddoHzZq_WOUcd1jeca5nAXjeMu4xSJ7bykznRkCek-kc6ge2FYHSvE1xqLTRP4KCVgl_M__4tO_9G_h5WL06G-dnn89M38JxTZU2shNuF5dn93L-FpdrN3zXS_xPDUwY6 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+lower+plasma+adiponectin+levels+and+higher+plasma+thrombin+generation+parameters+in+men+with+type+2+diabetes%3A+role+of+plasma+triglycerides&rft.jtitle=Journal+of+endocrinological+investigation&rft.au=Mantovani%2C+A.&rft.au=Danese%2C+E.&rft.au=Salvagno%2C+G.+L.&rft.au=Gelati%2C+M.&rft.date=2021-03-01&rft.pub=Springer+International+Publishing&rft.eissn=1720-8386&rft.volume=44&rft.issue=3&rft.spage=547&rft.epage=555&rft_id=info:doi/10.1007%2Fs40618-020-01340-3&rft.externalDocID=10_1007_s40618_020_01340_3 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1720-8386&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1720-8386&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1720-8386&client=summon |